Literature DB >> 16040476

Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation.

Anne Kärki1, Riitta Simonen, Esko Mälkiä, James Selfe.   

Abstract

OBJECTIVE: To describe the impairments of upper body and limbs, activity limitations and participation restrictions 6 and 12 months after operation for breast cancer and to examine the impact of impairments on activity limitations.
DESIGN: A prospective survey 6 and 12 months after operation. PATIENTS: Ninety-six breast cancer patients.
METHODS: A questionnaire for assessing the impairments, activity limitations and participation restrictions was developed.
RESULTS: The most common impairments 6 months after operation were breast and axilla scar tightness, axilla oedema and neck-shoulder pain. At 12-month follow-up the breast scar tightness (p=0.008) and axilla oedema (p=0.023) decreased, and limb ache (p=0.005) increased significantly. The most limiting impairments were axilla oedema and limb numbness 6 months after operation, and at 12-month follow-up axilla oedema. Lifting, carrying and reaching out caused worsening of impairments to more than half of the respondents at 6-month follow-up. Regression analysis showed that many impairments together were determinants of activity limitations and sleep impairment. Participation restrictions were constant. Respondents had not given up participation in activities in the home, but some had abandoned leisure activities and felt that their work ability had decreased.
CONCLUSION: Impairments and their impact on activities were frequent and constant. There is an urgent need for developing rehabilitation protocols for breast cancer patients.

Entities:  

Mesh:

Year:  2005        PMID: 16040476     DOI: 10.1080/16501970410024181

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  39 in total

1.  Can ICF model for patients with breast-cancer-related lymphedema predict quality of life?

Authors:  Jau-Yih Tsauo; Hsiu-Chuan Hung; Han-Ju Tsai; Chiun-Sheng Huang
Journal:  Support Care Cancer       Date:  2010-04-06       Impact factor: 3.603

2.  Clinician's Commentary on Tatham et al.(1.).

Authors:  Kristen Macdonell
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

Review 3.  A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema.

Authors:  Mohammed Taher Ahmed Omar; Afaf Ahmed Mohamed Shaheen; Hamayun Zafar
Journal:  Support Care Cancer       Date:  2012-08-09       Impact factor: 3.603

4.  Problem-solving strategies of women undergoing chemotherapy for breast cancer.

Authors:  Kathleen D Lyons; Kelly S Erickson; Mark T Hegel
Journal:  Can J Occup Ther       Date:  2012-02       Impact factor: 1.614

5.  Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).

Authors:  Judith O Hopkins; Jake Allred; Arti Hurria; Aminah Jatoi; Jacqueline M Lafky; Harvey Cohen; Clifford Hudis; Eric Winer; Jeanne Mandelblatt; Ann Partridge; Lisa Carey; Hyman B Muss
Journal:  Breast Cancer Res Treat       Date:  2017-08-20       Impact factor: 4.872

6.  Risk factors of impairment of shoulder function after axillary dissection for breast cancer.

Authors:  Masato Kikuuchi; Yoshiteru Akezaki; Eiji Nakata; Natsumi Yamashita; Ritsuko Tominaga; Hideaki Kurokawa; Makiko Hamada; Kenjiro Aogi; Shozo Ohsumi; Tetsuya Tsuji; Shinsuke Sugihara
Journal:  Support Care Cancer       Date:  2020-05-28       Impact factor: 3.603

7.  Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care.

Authors:  Nicole L Stout; Lucinda A Pfalzer; Barbara Springer; Ellen Levy; Charles L McGarvey; Jerome V Danoff; Lynn H Gerber; Peter W Soballe
Journal:  Phys Ther       Date:  2011-09-15

8.  Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life.

Authors:  Sandra C Hayes; Sheree Rye; Diana Battistutta; Tracey DiSipio; Beth Newman
Journal:  Health Qual Life Outcomes       Date:  2010-08-31       Impact factor: 3.186

9.  Enhancing return-to-work in cancer patients, development of an intervention and design of a randomised controlled trial.

Authors:  Sietske J Tamminga; Angela G E M de Boer; Jos H A M Verbeek; Taina Taskila; Monique H W Frings-Dresen
Journal:  BMC Cancer       Date:  2010-07-01       Impact factor: 4.430

Review 10.  Roles of integrins in tumor angiogenesis and lymphangiogenesis.

Authors:  Barbara Garmy-Susini; Judith A Varner
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.